These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Radiotherapy of malignant nasal tumors in 21 dogs. Thrall DE, Harvey CE. J Am Vet Med Assoc; 1983 Sep 15; 183(6):663-6. PubMed ID: 6629976 [Abstract] [Full Text] [Related]
4. Survival times for canine intranasal sarcomas treated with radiation therapy: 86 cases (1996-2011). Sones E, Smith A, Schleis S, Brawner W, Almond G, Taylor K, Haney S, Wypij J, Keyerleber M, Arthur J, Hamilton T, Lawrence J, Gieger T, Sellon R, Wright Z. Vet Radiol Ultrasound; 2013 Sep 15; 54(2):194-201. PubMed ID: 23278974 [Abstract] [Full Text] [Related]
6. Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs. Théon AP, Madewell BR, Harb MF, Dungworth DL. J Am Vet Med Assoc; 1993 May 01; 202(9):1469-75. PubMed ID: 8496103 [Abstract] [Full Text] [Related]
7. Limb-sparing treatment for osteosarcoma in dogs. LaRue SM, Withrow SJ, Powers BE, Wrigley RH, Gillette EL, Schwarz PD, Straw RC, Richter SL. J Am Vet Med Assoc; 1989 Dec 15; 195(12):1734-44. PubMed ID: 2599960 [Abstract] [Full Text] [Related]
8. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast. Trombetta M, Julian TB, Werts DE, McWilliams W, Kim Y, Miften M, Parda D. Am J Clin Oncol; 2009 Jun 15; 32(3):314-8. PubMed ID: 19451803 [Abstract] [Full Text] [Related]
9. Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors. Northrup NC, Roberts RE, Harrell TW, Allen KL, Howerth EW, Gieger TL. J Am Anim Hosp Assoc; 2004 Jun 15; 40(4):309-15. PubMed ID: 15238561 [Abstract] [Full Text] [Related]
10. Prognostic factors and survival after radiotherapy for intranasal neoplasms in dogs: 70 cases (1974-1985). Evans SM, Goldschmidt M, McKee LJ, Harvey CE. J Am Vet Med Assoc; 1989 May 15; 194(10):1460-3. PubMed ID: 2722643 [Abstract] [Full Text] [Related]
11. Re-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field. Pearlstone DB, Janjan NA, Feig BW, Yasko AW, Hunt KK, Pollock RE, Lawyer A, Horton J, Pisters PW. Cancer J Sci Am; 1999 May 15; 5(1):26-33. PubMed ID: 10188058 [Abstract] [Full Text] [Related]
12. Reirradiation of recurrent canine nasal tumors. Bommarito DA, Kent MS, Selting KA, Henry CJ, Lattimer JC. Vet Radiol Ultrasound; 2011 May 15; 52(2):207-12. PubMed ID: 21388476 [Abstract] [Full Text] [Related]
13. Use of radiotherapy for the treatment of intranasal tumors in cats: six cases (1980-1985). Straw RC, Withrow SJ, Gillette EL, McChesney AE. J Am Vet Med Assoc; 1986 Oct 15; 189(8):927-9. PubMed ID: 3533873 [Abstract] [Full Text] [Related]
14. Radiotherapy of malignant nasal tumors in 67 dogs. Adams WM, Withrow SJ, Walshaw R, Turrell JM, Evans SM, Walker MA, Kurzman ID. J Am Vet Med Assoc; 1987 Aug 01; 191(3):311-5. PubMed ID: 3654292 [Abstract] [Full Text] [Related]
15. Reirradiation of tumors in cats and dogs. Turrel JM, Théon AP. J Am Vet Med Assoc; 1988 Aug 15; 193(4):465-9. PubMed ID: 3139592 [Abstract] [Full Text] [Related]
16. Image-guided transnasal cryoablation of a recurrent nasal adenocarcinoma in a dog. Murphy SM, Lawrence JA, Schmiedt CW, Davis KW, Lee FT, Forrest LJ, Bjorling DE. J Small Anim Pract; 2011 Jun 15; 52(6):329-33. PubMed ID: 21627662 [Abstract] [Full Text] [Related]
17. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view. Nickers P, Thissen B, Jansen N, Deneufbourg JM. Radiother Oncol; 2006 Jan 15; 78(1):47-52. PubMed ID: 16216365 [Abstract] [Full Text] [Related]
18. Intraoperative versus interstitial radiotherapy: a comparison of morbidity in the head and neck. Close LG, Morrish TN, Nguyen P. Laryngoscope; 1993 Mar 15; 103(3):231-46. PubMed ID: 8441310 [Abstract] [Full Text] [Related]
19. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer. Jo Y, Hiratsuka J, Fujii T, Takenaka A, Fujisawa M. Urology; 2004 Sep 15; 64(3):556-60. PubMed ID: 15351592 [Abstract] [Full Text] [Related]
20. Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system? Nickers P, Lenaerts E, Thissen B, Deneufbourg JM. Radiother Oncol; 2005 Feb 15; 74(2):131-6. PubMed ID: 15734200 [Abstract] [Full Text] [Related] Page: [Next] [New Search]